• Investing in Pharma (Part 1) - Divi's Laboratories

  • Jan 8 2024
  • Durée: 11 min
  • Podcast

Page de couverture de Investing in Pharma (Part 1) - Divi's Laboratories

Investing in Pharma (Part 1) - Divi's Laboratories

  • Résumé

  • Investing in Pharma (Part 1) - Divi's Laboratories 

    Being one of the biggest API manufacturers in the world, Divi's stock prices are quite expensive. In this episode, I breakdown the reasons as to why the company is trading at a PE of 71 while also giving an account of the risks the company faces and; eventually, attempting to decide if the stock prices are justified. Tune in to find out more about Divi's Labs.

    Read the full blog here

    Voir plus Voir moins
activate_primeday_promo_in_buybox_DT

Ce que les auditeurs disent de Investing in Pharma (Part 1) - Divi's Laboratories

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.